Biomedical and Entrepreneurship Training for Aging (BETA)

老龄化生物医学和创业培训（BETA）

• 批准号: 10502024
• 负责人: Anandhi Upendran
• 金额: $ 14.26万
• 依托单位: UNIVERSITY OF MISSOURI-COLUMBIA
• 依托单位国家: 美国
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-08-15 至 2027-04-30
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10502024
• 关键词: Academia; Age-Years; Aging; Alzheimer' s Disease; Alzheimer' s disease related dementia; Behavioral; Biological Sciences; Brain; Businesses; Capital; Cities; Clinical; Cognitive; Communication; Complement; Complex; Delirium; Dementia; Development; Devices; Discipline; Disease; Doctor of Philosophy; Ecosystem; Education; Elderly; Engineering; Entrepreneurship; Evaluation Research; Faculty; Fellowship; Funding; Geriatrics; Government; Government Agencies; Health; Health Care Sector; Health Occupations; Health system; Healthcare; Human Resources; Immersion; Incubators; Individual; Industrialization; Industry; Intellectual Property; Journalism; Kansas; Longevity; Malignant Neoplasms; Mentors; Midwestern United States; Missouri; Modeling; Neurocognitive; Neurosciences; Neurosciences Research; Nursing Schools; Pathway interactions; Personal Satisfaction; Play; Population; Postdoctoral Fellow; Precision Health; Process; Quality of life; Research; Research Personnel; Research Training; Role; Schools; Science; Small Business Innovation Research Grant; Small Business Technology Transfer Research; Source; Specialist; Stroke; Students; Syndrome; System; Talents; Technology; Technology Transfer; Training; Training Programs; Translational Research; United States National Institutes of Health; Universities; Work; age related; aging population; base; career; college; combat; commercialization; design; diversity and inclusion; experience; falls; frailty; graduate student; healthy aging; higher education; improved; innovation; medical schools; member; novel; novel therapeutics; post-doctoral training; programs; recruit; rehabilitation technology; research clinical testing; responsible research conduct; skills

The proportion of the US population of ≥65 years of age is expected to reach 22% by 2050. Healthcare innovations have played a crucial role in improving the health and well-being of the elderly population. Nevertheless, a major gap persists between academia and industry that must be bridged to drive innovation and commercialization of new drugs, devices, and technologies to combat age-related disorders, including Alzheimer’s disease (AD) and Alzheimer’s Disease related dementia (ADRD). Graduate students and post-doctoral trainees pursuing advanced training in age-related diseases constitute a vital work force capable of filling this gap; however, current training programs do not provide the business and communication skills needed to empower these trainees to fill this void. The overarching objective of the application is to grow the scientific work force promoting healthy aging through the creation of the Biomedical Entrepreneurship Training for Aging (BETA) program. MU is ideally suited to serve as the hub of an educational program focusing on graduate students and postdoctoral fellows pursuing careers in aging-related disciplines, as it co-localizes on one campus a school of medicine, college of engineering, school of health professions, college of nursing, school of journalism, and the comprehensive UM Health System. MU has outstanding programs that support entrepreneurial education, including the Life Science Innovation & Entrepreneurship Graduate Program, the Midwest Biomedical Accelerator Consortium, an NIH-funded Research Evaluation and Commercialization Hub (REACH), a Coulter Biomedical Accelerator, and the MU Life Science Business Incubator. The UM System, with >70,000 students and hundreds of graduate programs, provides a robust source of BETA trainees, including the MU Interdisciplinary Neuroscience Graduate Training Program, University of Missouri-Kansas City (UMKC) Doctoral Program in Applied Cognitive &Brain Sciences, University of Missouri-St. Louis (UMSL) Behavioral Neuroscience PhD program, and the Missouri S&T (MS&T) Graduate Program in Biological Sciences. MU also has a long-standing partnership with Lincoln University, an HBU that will source students to enable diversity and inclusion. BETA leverages the commercialization and educational expertise of the statewide UM System to create a network that recruits and mentors a diverse array of trainees and provides them with the biomedical innovation and communication skills needed to become highly productive members of the scientific work force devoted to improving the health and wellbeing of the aging population.

预计到2050年，美国65岁以上人口的比例将达到22%。医疗保健创新在改善老年人的健康和福祉方面发挥了至关重要的作用。然而，学术界和工业界之间仍然存在重大差距，必须弥合这一差距，以推动新药、设备和技术的创新和商业化，以对抗与年龄相关的疾病，包括阿尔茨海默病（AD）和阿尔茨海默病相关痴呆症（ADRD）。研究生和博士后学员追求与年龄有关的疾病的高级培训构成了能够填补这一空白的重要劳动力;然而，目前的培训计划不提供所需的业务和沟通技能，使这些学员填补这一空白。该应用程序的总体目标是通过创建生物医学创业培训老龄化（BETA）计划来发展促进健康老龄化的科学劳动力。MU非常适合作为教育计划的中心，专注于研究生和博士后研究员在老龄化相关学科的职业生涯，因为它在一个校园内共同定位医学，工程学院，卫生专业学院，护理学院，新闻学院和综合UM卫生系统。MU拥有支持创业教育的优秀项目，包括生命科学创新与创业研究生项目，中西部生物医学加速器联盟，NIH资助的研究评估和商业化中心（REACH），Coulter生物医学加速器和MU生命科学企业孵化器。UM系统拥有超过70，000名学生和数百个研究生课程，提供了强大的BETA学员来源，包括MU跨学科神经科学研究生培训计划，密苏里大学堪萨斯城分校（UMKC）应用认知和脑科学博士课程，密苏里大学圣路易斯分校（UMSL）行为神经科学博士课程，和密苏里州科技（MS&T）生物科学研究生项目。MU还与林肯大学建立了长期的合作伙伴关系，这是一所HBU，将为学生提供多样性和包容性。BETA利用全州UM系统的商业化和教育专业知识，创建一个网络，招募和指导各种各样的学员，并为他们提供成为致力于改善老龄人口健康和福祉的科学劳动力的高产成员所需的生物医学创新和沟通技能。